The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury

Journal of Neurotrauma

Volumn 27, Issue 1, 2010, Pages 139-149

  Springer, Joe E ^a   Rao, Ravikumar Rangaswamy ^a   Lim, Hyang Ran ^b,c   Cho, Sung Ig ^b,c   Moon, Gyoeng Joon ^b,c   Lee, Hee Young ^b,c   Park, Eui Jin ^b,c   Gwag, Byoung Joo ^b,c   Noh, Jai Sung ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Ajou University School of Medicine   (South Korea)

^c Neurotech Pharmaceuticals Co   (South Korea)

Author keywords

Excitotoxicity; Functional recovery; Oxidative stress; Spinal cord contusion; Tissue sparing

Indexed keywords

2 HYDROXY 5 (2,3,5,6 TETRAFLUORO 4 TRIFLUOROMETHYLBENZYLAMINO)BENZOIC ACID; FREE RADICAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU 2000; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; EXCITOTOXICITY; FEMALE; KINEMATICS; LOCOMOTION; MOTOR CONTROL; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; SPINAL CORD INJURY; STEREOLOGY;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BENZOIC ACIDS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICALS; MITOCHONDRIA; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 76349090715     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.0952     Document Type: Article

References (57)

1. Agrawal, S.K., and Fehlings, M.G. (1997). Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J. Neurosci. 17, 1055-1063.
2. Amende, I., Kale, A., McCue, S., Glazier, S., Morgan, J.P., and Hampton, T.G. (2005). Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J. Neuroengineering Rehabil. 2, 20.
3. Azbill, R.D., Mu, X., Bruce-Keller, A.J., Mattson, M.P., and Springer, J.E. (1997). Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765, 283-290.
4. Baines, C.P., Kaiser, R.A., Purcell, N.H., Blair, N.S., Osinska, H., Hambleton, M.A., Brunskill, E.W., Sayen, M.R., Gottlieb, R.A., Dorn, G.W., Robbins, J., and Molkentin, J.D. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662.
5. Baptiste, D.C., and Fehlings, M.G. (2006). Pharmacological approaches to repair the injured spinal cord. J. Neurotrauma 23, 318-334.
6. Baptiste, D.C., Tighe, A., and Fehlings, M.G. (2009). Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury. Expert Opin. Investig. Drugs 18, 663-673.
7. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
8. Basso, D., Beattie, M., and Breshnahan, J. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
9. Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M.A., and Bernardi, P. (2005). Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280, 18558-18561.
10. Blight, A.R., and Zimber, M.P. (2001). Acute spinal cord injury: pharmacotherapy and drug development perspectives. Curr. Opin. Investig. Drugs 2, 801-808.
11. Brown, M.R., Geddes, J.W., and Sullivan, P.G. (2004). Brain regionspecific, age-related, alterations in mitochondrial responses to elevated calcium. J. Bioenerg. Biomembr. 36, 401-406.
12. Brustovetsky, N., Brustovetsky, T., Jemmerson, R., and Dubinsky, J.M. (2002). Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J. Neurochem. 80, 207-218.
13. Brustovetsky, N., Brustovetsky, T., Purl, K.J., Capano, M., Crompton, M., and Dubinsky, J.M. (2003). Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 23, 4858-4867.
14. Cande, C., Cohen, I., Daugas, E., Ravagnan, L., Larochette, N., Zamzami, N., and Kroemer, G. (2002). Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84, 215-222.
15. Chai, J., Du, C., Wu, J.W., Kyin, S., Wang, X., and Shi, Y. (2000). Structural and biochemical basis of apoptotic activation by Smac=DIABLO. Nature 406, 855-862.
16. Chen, H.S., Wang, Y.F., Rayudu, P.V., Edgecomb, P., Neill, J.C., Segal, M.M., Lipton, S.A., and Jensen, F.E. (1998). Neuroprotective concentrations of the N-methyl-D-aspartate openchannel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86, 1121-1132.
17. De Cristobal, J., Madrigal, J.L., Lizasoain, I., Lorenzo, P., Leza, J.C., and Moro, M.A. (2002). Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats. Neuroreport 13, 217-221.
18. Friberg, H., and Wieloch, T. (2002). Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84, 241-250.
19. Gionchetti, P., Guarnieri, C., Campieri, M., Belluzzi, A., Brignola, C., Iannone, P., Miglioli, M., and Barbara, L. (1990). Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ). Gut 31, 730-731.
20. Grilli, M., Pizzi, M., Memo, M., and Spano, P. (1996). Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274, 1383-1385.
21. Grossman, S.D., Wolfe, B.B., Yasuda, R.P., and Wrathall, J.R. (2000). Changes in NMDA receptor subunit expression in response to contusive spinal cord injury. J. Neurochem. 75, 174-184.
22. Gwag, B.J., Lee, Y.A., Ko, S.Y., Lee, M.J., Im, D.S., Yun, B.S., Lim, H.R., Park, S.M., Byun, H.Y., Son, S.J., Kwon, H.J., Lee, J.Y., Cho, J.Y., Won, S.J., Kim, K.W., Ahn, Y.M., Moon, H.S., Lee, H.U., Yoon, S.H., Noh, J.H., Chung, J.M., and Cho, S.I. (2007). Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J. Cereb. Blood Flow Metab. 27, 1142-1151.
23. Hall, E.D., Braughler, J.M., and McCall, J.M. (1992). Antioxidant effects in brain and spinal cord injury. J. Neurotrauma 9, Suppl. 1, S165-172.
24. Hall, E.D., and Springer, J.E. (2004). Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1, 80-100.
25. Hampton, T.G., Stasko, M.R., Kale, A., Amende, I., and Costa, A.C. (2004). Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol. Behav. 82, 381-389.
26. Hansson, M.J., Persson, T., Friberg, H., Keep, M.F., Rees, A., Wieloch, T., and Elmer, E. (2003). Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res. 960, 99-111.
27. Jin, Y., McEwen, M.L., Nottingham, S.A., Maragos, W.F., Dragicevic, N.B., Sullivan, P.G., and Springer, J.E. (2004). The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. J. Neurotrauma 21, 1396-1404.
28. Kale, A., Amende, I., Meyer, G.P., Crabbe, J.C., and Hampton, T.G. (2004). Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. Alcohol Clin. Exp. Res. 28, 1839-1848.
29. Kim, E.Y., Chang, S.Y., Chung, J.M., Ryu, B.R., Joo, C.K., Moon, H.S., Kang, K., Yoon, S.H., Han, P.L., and Gwag, B.J. (2001). Attenuation of Zn2+ neurotoxicity by aspirin: role of N-type Ca2+ channel and the carboxyl acid group. Neurobiol. Dis. 8, 774-783.
30. Ko, H.W., Park, K.Y., Kim, H., Han, P.L., Kim, Y.U., Gwag, B.J., and Choi, E.J. (1998). Ca2+ mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J. Neurochem. 71, 1390-1395.
31. Li, S., Kim, J.E., Budel, S., Hampton, T.G., and Strittmatter, S.M. (2005). Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol. Cell Neurosci. 29, 26-39.
32. Liu, D., Xu, G.Y., Pan, E., and McAdoo, D.J. (1999). Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 93, 1383-1389.
33. McAdoo, D.J., Xu, G.Y., Robak, G., and Hughes, M.G. (1999). Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp. Neurol. 159, 538-544.
34. McEwen, M.L., and Springer, J.E. (2006). Quantification of locomotor recovery following spinal cord contusion in adult rats. J. Neurotrauma 23, 1632-1653.
35. McEwen, M.L., Sullivan, P.G., and Springer, J.E. (2007). Pretreatment with the cyclopsorin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats. J. Neurotrauma 24, 613-624.
36. Mouton, P.R., Gokhale, A.M., Ward, N.L., and West, M.J. (2002). Stereological length estimation using spherical probes. J. Microsc. 206, 54-64.
37. Mu, X., Azbill, R.D., and Springer, J.E. (2000a). Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J. Neurotrauma 17, 773-780.
38. Mu, X., Azbill, R.D., and Springer, J.E. (2000b). Riluzole improves measures of oxidative stress in traumatic spinal cord injury. Brain Res. 870, 66-72.
39. Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., and Tsujimoto, Y. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658.
40. Noh, J., Lee, E.S., and Chung, J.M. (2009). The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4- trifluoromethyl-benzylamino)- benzoic acid, is a gating modifier in cultured mouse cortical neurons. J. Neurochem. 109, 1261-1271.
41. Olney, J.W., Labruyere, J., Wang, G., Wozniak, D.F., Price, M.T., and Sesma, M.A. (1991). NMDA antagonist neurotoxicity: mechanism and prevention. Science 254, 1515-1518.
42. Petronilli, V., Penzo, D., Scorrano, L., Bernardi, P., and Di Lisa, F. (2001). The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J. Biol. Chem. 276, 12030-12034.
43. Rabchevsky, A.G., Fugaccia, I., Sullivan, P.G., and Scheff, S.W. (2001). Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18, 513-522.
44. Ravikumar, R., Fugaccia, I., Scheff, S.W., Geddes, J.W., Srinivasan, C., and Toborek, M. (2005). Nicotine attenuates morphological deficits in a contusion model of spinal cord injury. J. Neurotrauma 22, 240-251.
45. Ravikumar, R., McEwen, M.L., and Springer, J.E. (2007). Posttreatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion. J. Neurotrauma 24, 1618-1630.
46. Reed, M.G., and Howard, C.V. (1998). Surface-weighted star volume: concept and estimation. J. Microsc. 190, 350-356.
47. Ryu, B.R., Lee, Y.A., Won, S.J., Noh, J.H., Chang, S.Y., Chung, J.M., Choi, J.S., Joo, C.K., Yoon, S.H., and Gwag, B.J. (2003). The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. J. Pharmacol. Exp. Ther. 305, 48-56.
48. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E., Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
49. Schinzel, A.C., Takeuchi, O., Huang, Z., Fisher, J.K., Zhou, Z., Rubens, J., Hetz, C., Danial, N.N., Moskowitz, M.A., and Korsmeyer, S.J. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 102, 12005-12010.
50. Sharma, N., Baxter, M.G., Petravicz, J., Bragg, D.C., Schienda, A., Standaert, D.G., and Breakefield, X.O. (2005). Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 5351-5355.
51. Springer, J.E., Azbill, R.D., Mark, R.J., Begley, J.G., Waeg, G., and Mattson, M.P. (1997). 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68, 2469-2476.
52. Sullivan, P.G., Krishnamurthy, S., Patel, S.P., Pandya, J.D., and Rabchevsky, A.G. (2007). Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J. Neurotrauma 24, 991-999.
53. Sullivan, P.G., Rabchevsky, A.G., Waldmeier, P.C., and Springer, J.E. (2005). Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79, 231-239.
54. Vartiainen, N., Goldsteins, G., Keksa-Goldsteine, V., Chan, P.H., and Koistinaho, J. (2003). Aspirin inhibits p44=42 mitogenactivated protein kinase and is protective against hypoxia= reoxygenation neuronal damage. Stroke 34, 752-757.
55. Wooley, C.M., Sher, R.B., Kale, A., Frankel, W.N., Cox, G.A., and Seburn, K.L. (2005). Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32, 43-50.
56. Wrathall, J.R., Teng, Y.D., and Choiniere, D. (1996). Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D- aspartate receptors. Exp. Neurol. 137, 119-126.
57. Wrathall, J.R., Teng, Y.D., Choiniere, D., and Mundt, D.J. (1992). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 586, 140-143.